In 2024, a study by Lin et al. showed that pre-treatment of HCC cells with irradiation increased in vivo migration and activity of CXCR2-armed GPC3-targeting CAR-NK92 cells, through MICA/B and ULBP1 upregulation (131). The gene discussed is GPC3; the disease is hepatocellular carcinoma.